Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RanQ is a premier Indian manufacturer specializing in high-quality pharmaceutical excipients used in solid dosage formulations. The company is globally recognized for its production of essential components such as Microcrystalline Cellulose (MCC), Croscarmellose Sodium, and Sodium Starch Glycolate. Operating out of GMP-certified facilities, RanQ serves the pharmaceutical, nutraceutical, and food industries by providing ingredients that meet international pharmacopoeial standards including USP, BP, and EP. Their products are designed to enhance the compressibility, disintegration, and overall stability of drug formulations. With a strong focus on material science and quality control, RanQ has established itself as a reliable partner for drug manufacturers worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RanQ.